tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Neuronetics’ Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsNeuronetics’ Earnings Call: Growth Amid Challenges
3M ago
Neuronetics sees Q4 revenue $40M-$43M, consensus $43.06M
Premium
The Fly
Neuronetics sees Q4 revenue $40M-$43M, consensus $43.06M
3M ago
Neuronetics sees FY25 revenue $147M-$150M, consensus $151.03M
Premium
The Fly
Neuronetics sees FY25 revenue $147M-$150M, consensus $151.03M
3M ago
Neuronetics announces three-year agreement with Elite DNA Behavioral Health
PremiumThe FlyNeuronetics announces three-year agreement with Elite DNA Behavioral Health
3M ago
Neuronetics management to meet virtually with Piper Sandler
Premium
The Fly
Neuronetics management to meet virtually with Piper Sandler
4M ago
Neuronetics announces New York State Medicaid to begin covering TMS services
Premium
The Fly
Neuronetics announces New York State Medicaid to begin covering TMS services
5M ago
Neuronetics reports Q2 EPS (15c) vs. (33c) last year
PremiumThe FlyNeuronetics reports Q2 EPS (15c) vs. (33c) last year
6M ago
Neuronetics sees Q3 revenue $37M-$39M, consensus $38.22M
Premium
The Fly
Neuronetics sees Q3 revenue $37M-$39M, consensus $38.22M
6M ago
Neuronetics sees FY25 revenue $149M-$155M, consensus $151.01M
Premium
The Fly
Neuronetics sees FY25 revenue $149M-$155M, consensus $151.01M
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100